Winning against COVID-19: The implications for biopharma
This article from Mckinsey & Company considers the biopharma sector and highlights how biopharma companies act individually and collectively in the coming weeks and months will not only shape the outcome of the pandemic, but also the reputation of the biopharma industry for decades. It explains how the world is looking to biopharma and the medical-products industry for a way out of the current global pandemic. This contribution spans testing, ventilators and other critical medical devices, repurposed and novel therapeutics, and vaccines. As such the industry is responsible for providing the path to our ‘next normal’. They conclude companies need to work together not only to shape a positive outcome for the pandemic but also to safeguard their legitimacy to operate in the decades ahead.